Compounds and compositions as RAF kinase inhibitors
申请人:NOVARTIS AG
公开号:US10167279B2
公开(公告)日:2019-01-01
The present invention provides compounds of Formula (I) and (II) as described herein, and salts thereof, and therapeutic uses of these compounds for treatment of disorders associated with Raf kinase activity. The invention further provides pharmaceutical compositions comprising these compounds, and compositions comprising these compounds and a therapeutic co-agent.
COMPOUNDS AND COMPOSITIONS AS RAF KINASE INHIBITORS
申请人:Novartis AG
公开号:EP3191478A1
公开(公告)日:2017-07-19
[EN] IMIDAZOLE MACROCYCLES FOR THE TREATMENT OF AUTOIMMUNE DISEASE<br/>[FR] MACROCYCLES D'IMIDAZOLE POUR LE TRAITEMENT D'UNE MALADIE AUTO-IMMUNE
申请人:[en]F. HOFFMANN-LA ROCHE AG
公开号:WO2023148129A1
公开(公告)日:2023-08-10
The present invention relates to compounds of formula (Ia), (Ia), wherein R2, M1, M2, M3, Q1and Q2are as described herein, and their pharmaceutically acceptable salt thereof, and compositions including the compounds and methods of using the compounds.